HIV-positive TB patients on ART (antiretroviral therapy) in Ghana
Ghana: HIV-positive TB patients on ART (antiretroviral therapy) was 96.0% in 2024. ◆ Volatile
HIV-positive TB patients on ART (antiretroviral therapy) in Ghana, 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Ghana recorded 96.0% for hiv-positive tb patients on art (antiretroviral therapy) in 2024.
That represents a change of down 2.0% on the previous year and up 146.2% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Ghana peaked at 100.0% in 2003 and was at its lowest, 14.0%, in 2006.
That places Ghana 74th out of 144 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
HIV-positive TB patients on ART (antiretroviral therapy) in Ghana, year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 100.0% | — |
| 2005 | 37.0% | -63.0% |
| 2006 | 14.0% | -62.2% |
| 2007 | 17.0% | +21.4% |
| 2008 | 24.0% | +41.2% |
| 2009 | 24.0% | +0.0% |
| 2010 | 18.0% | -25.0% |
| 2011 | 28.0% | +55.6% |
| 2012 | 37.0% | +32.1% |
| 2013 | 37.0% | +0.0% |
| 2014 | 39.0% | +5.4% |
| 2015 | 39.0% | +0.0% |
| 2016 | 43.0% | +10.3% |
| 2017 | 53.0% | +23.3% |
| 2018 | 46.0% | -13.2% |
| 2019 | 75.0% | +63.0% |
| 2020 | 90.0% | +20.0% |
| 2021 | 96.0% | +6.7% |
| 2022 | 97.0% | +1.0% |
| 2023 | 98.0% | +1.0% |
| 2024 | 96.0% | -2.0% |
Ghana compared with similar countries
- Ghana's 96.0% is above the median for lower middle income countries, which is 96.0%, 1.0× the median. (43 countries reporting)
- Ghana's 96.0% is below the median for Sub-Saharan Africa, which is 97.0%, 99% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 36.0% | 14.0% | 100.0% | 6 |
| 2010s | 41.5% | 18.0% | 75.0% | 10 |
| 2020s | 95.4% | 90.0% | 98.0% | 5 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 986.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,361 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.5623 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.06 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5816 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Ghana?
- Hiv-positive tb patients on art (antiretroviral therapy) in Ghana was 96.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Ghana?
- The highest recorded value was 100.0% in 2003.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Ghana?
- The lowest recorded value was 14.0% in 2006.
- How does Ghana rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Ghana ranks 74th out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Ghana?
- Over the last ten years it is up 146.2%. The long-run trend across the full record is volatile.
- Where does this Ghana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 21 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).